Aclarion (NASDAQ:ACON – Get Free Report) and Health Catalyst (NASDAQ:HCAT – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Aclarion and Health Catalyst, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aclarion | 1 | 0 | 1 | 0 | 2.00 |
| Health Catalyst | 1 | 7 | 3 | 0 | 2.18 |
Aclarion presently has a consensus target price of $7.50, indicating a potential upside of 206.75%. Health Catalyst has a consensus target price of $2.45, indicating a potential upside of 38.89%. Given Aclarion’s higher possible upside, analysts plainly believe Aclarion is more favorable than Health Catalyst.
Risk and Volatility
Insider & Institutional Ownership
7.5% of Aclarion shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 0.0% of Aclarion shares are owned by company insiders. Comparatively, 19.4% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Aclarion and Health Catalyst’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aclarion | -10,948.81% | -59.34% | -56.12% |
| Health Catalyst | -90.61% | -1.83% | -0.80% |
Earnings & Valuation
This table compares Aclarion and Health Catalyst”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aclarion | $80,000.00 | 88.02 | -$7.23 million | ($7.40) | -0.33 |
| Health Catalyst | $311.14 million | 0.43 | -$177.97 million | ($3.68) | -0.48 |
Aclarion has higher earnings, but lower revenue than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.
Summary
Health Catalyst beats Aclarion on 10 of the 14 factors compared between the two stocks.
About Aclarion
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
About Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
